Increased Expression of Adherens Junction Components in Mouse Liver following Bile Duct Ligation.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
22 10 2019
Historique:
received: 02 09 2019
revised: 10 10 2019
accepted: 19 10 2019
entrez: 27 10 2019
pubmed: 28 10 2019
medline: 23 9 2020
Statut: epublish

Résumé

Adherens junctions, consisting of cadherins and catenins, are a group of cell-to-cell junctions that mediate mechanistic linkage between neighboring cells. By doing so, adherens junctions ensure direct intercellular contact and play an indispensable role in maintaining tissue architecture. Considering these critical functions, it is not surprising that adherens junctions are frequently involved in disease. In the present study, the effects of bile duct ligation-a surgical procedure to experimentally induce cholestatic and fibrotic liver pathology-on hepatic adherens junctions were investigated in mice. In essence, it was found that liver mRNA and protein levels of E-cadherin, β-catenin and γ-catenin drastically increase following bile duct ligation. These results could suggest a cytoprotective role for hepatic adherens junctions following bile duct ligation.

Identifiants

pubmed: 31652629
pii: biom9100636
doi: 10.3390/biom9100636
pmc: PMC6843439
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Exp Cell Res. 1992 Oct;202(2):477-86
pubmed: 1383015
J Genet Genomics. 2007 Oct;34(10):892-908
pubmed: 17945168
Am J Pathol. 2006 May;168(5):1500-12
pubmed: 16651617
Gastroenterology. 2015 Jun;148(7):1294-310
pubmed: 25747274
Oncogene. 2004 Jan 29;23(4):964-72
pubmed: 14661054
J Hepatol. 2018 May;68(5):1006-1017
pubmed: 29273475
Mol Biotechnol. 2013 Nov;55(3):217-26
pubmed: 23709336
Bioessays. 2001 Apr;23(4):311-8
pubmed: 11268036
Arch Toxicol. 2018 Aug;92(8):2607-2627
pubmed: 29987408
Mol Med Rep. 2014 Jun;9(6):2145-51
pubmed: 24691643
Dev Cell. 2009 Dec;17(6):788-99
pubmed: 20059949
Hepatology. 2010 Mar;51(3):737-40
pubmed: 20198628
Histochem Cell Biol. 2008 Mar;129(3):289-99
pubmed: 18197414
Dev Cell. 2009 Jul;17(1):9-26
pubmed: 19619488
Oncotarget. 2017 May 9;8(19):32270-32291
pubmed: 28416759
J Clin Invest. 2009 Jun;119(6):1420-8
pubmed: 19487818
Biochim Biophys Acta. 2003 Jun 5;1653(1):1-24
pubmed: 12781368
Curr Opin Cell Biol. 1997 Oct;9(5):683-90
pubmed: 9330872
Mol Reprod Dev. 2015 Jul-Aug;82(7-8):518-29
pubmed: 26153368
Hepatology. 2016 Nov;64(5):1652-1666
pubmed: 27533619
PLoS One. 2013 Aug 30;8(8):e72457
pubmed: 24023619
Cytokine Growth Factor Rev. 2000 Dec;11(4):273-82
pubmed: 10959075
Microsc Res Tech. 2011 May;74(5):421-9
pubmed: 20830702
J Vis Exp. 2015 Feb 10;(96):null
pubmed: 25741630
Nat Rev Mol Cell Biol. 2006 Feb;7(2):131-42
pubmed: 16493418
World J Gastroenterol. 2013 Mar 7;19(9):1380-6
pubmed: 23538893
Arch Toxicol. 2016 May;90(5):1025-1048
pubmed: 26047667
Hepatology. 2007 May;45(5):1298-305
pubmed: 17464972
Sci Rep. 2014 Oct 30;4:6835
pubmed: 25355493
Lab Invest. 2008 Feb;88(2):112-23
pubmed: 18059363
Hepatology. 2009 Dec;50(6):2007-13
pubmed: 19824076
PLoS One. 2018 Jan 16;13(1):e0191279
pubmed: 29338041
Br J Surg. 2008 May;95(5):646-56
pubmed: 18196571
J Biol Chem. 2007 Aug 10;282(32):23337-47
pubmed: 17562716
Biomed Rep. 2016 Mar;4(3):269-274
pubmed: 26998262
J Clin Invest. 2009 Jun;119(6):1429-37
pubmed: 19487819
Gene Expr. 2019 Apr 18;19(2):69-87
pubmed: 30646969
Am J Pathol. 2002 Apr;160(4):1229-38
pubmed: 11943708
Am J Pathol. 2015 Dec;185(12):3274-89
pubmed: 26485505
EMBO J. 2002 Mar 1;21(5):1021-30
pubmed: 11867530
J Hepatol. 2011 Dec;55(6):1256-62
pubmed: 21703193
Hum Pathol. 2000 May;31(5):558-65
pubmed: 10836294
Biomed Res Int. 2014;2014:361590
pubmed: 24738055
Genes Dev. 2000 Jun 1;14(11):1319-31
pubmed: 10837025
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Cell Mol Life Sci. 2015 Jul;72(13):2599-612
pubmed: 25687506
Crit Rev Toxicol. 2006 Apr;36(4):299-318
pubmed: 16809101
Am J Physiol Gastrointest Liver Physiol. 2013 Dec;305(12):G881-90
pubmed: 24157970
Am J Pathol. 2009 Sep;175(3):1056-65
pubmed: 19679878
Anal Biochem. 2014 Dec 15;467:1-3
pubmed: 25193447
Am J Physiol. 1999 May;276(5):R1249-57
pubmed: 10233014
Arch Toxicol. 2017 May;91(5):2245-2261
pubmed: 27826632
Toxicol Sci. 2001 Jun;61(2):389-94
pubmed: 11353148
Cold Spring Harb Perspect Biol. 2009 Dec;1(6):a002899
pubmed: 20457565

Auteurs

Raf Van Campenhout (R)

Department of In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium. raf.van.campenhout@vub.be.

Sara Crespo Yanguas (S)

Department of In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium. screspo@idibell.cat.

Axelle Cooreman (A)

Department of In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium. axelle.cooreman@vub.be.

Eva Gijbels (E)

Department of In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium. eva.anne.gijbels@vub.be.

Kaat Leroy (K)

Department of In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium. kaat.leroy@vub.be.

Vânia Vilas-Boas (V)

Department of In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium. vania.vilas.boas@vub.be.

Nick Devoogdt (N)

In Vivo Cellular and Molecular Imaging Laboratory, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium. ndevoogd@vub.be.

Serge Muyldermans (S)

Laboratory of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Pleinlaan 2, B-1050 Brussels, Belgium. serge.muyldermans@vub.be.

Bruno Cogliati (B)

Department of Pathology, School of Veterinary Medicine and Animal Science, University of São Paulo, Av. Prof. Dr. Orlando Marques de Paiva 87,05508-270 São Paulo, Brazil. bcogliati@usp.br.

Mathieu Vinken (M)

Department of In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium. mathieu.vinken@vub.be.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH